Benzinga's Top Upgrades, Downgrades For December 26, 2019

Downgrades Cantor Fitzgerald downgraded Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) from Overweight to Neutral. Spectrum Pharmaceuticals shares closed at $8.75 on Tuesday.

Benzinga · 12/26/2019 16:29

Downgrades

  • Cantor Fitzgerald downgraded Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) from Overweight to Neutral. Spectrum Pharmaceuticals shares closed at $8.75 on Tuesday.